EORTC prostate cancer trials: what have we learnt?
- 31 August 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 43 (2) , 159-165
- https://doi.org/10.1016/s1040-8428(02)00028-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European Organization for Research and Treatment of Cancer Genitourinary GroupJournal of Clinical Oncology, 2001
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working GroupJournal of Clinical Oncology, 1999
- RANDOMIZED PHASE II TRIAL ASSESSING ESTRAMUSTINE AND VINBLASTINE COMBINATION CHEMOTHERAPY VS. ESTRAMUSTINE ALONE IN PATIENTS WITH HORMONE ESCAPED PROGRESSIVE METASTATIC PROSTATE CANCERJournal of Urology, 1999
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of life in prostate cancerThe Prostate, 1992
- Comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: An interim analysis of EORTC-GU group study no. 30865The Journal of Steroid Biochemistry and Molecular Biology, 1990
- Low-dose fortnightly methotrexate in advanced prostate cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Mitomycin-C in the treatment of metastatic prostate cancer: report on an EORTC phase II studyWorld Journal of Urology, 1986
- Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological GroupJournal of Urology, 1986
- An EORTC phase II study of vindesine in advanced prostate cancerEuropean Journal of Cancer and Clinical Oncology, 1983